Marketing-authorisation holder · Canada
Lundbeck Canada Inc
26 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
26 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 26
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CELEXA 10 MG10 mg · Tablet | Citalopram | Canada | Authorised | |
| CELEXA 20 MG20 mg · Tablet | Citalopram | Canada | Marketed | 1999 |
| CELEXA 40 MG40 mg · Tablet | Citalopram | Canada | Marketed | 1999 |
| CIPRALEX -10MG10 mg · Tablet | Escitalopram | Canada | Marketed | 2005 |
| CIPRALEX -15MG15 mg · Tablet | Escitalopram | Canada | Authorised | |
| CIPRALEX -20MG20 mg · Tablet | Escitalopram | Canada | Marketed | 2005 |
| CIPRALEX -5MG5 mg · Tablet | Escitalopram | Canada | Authorised | |
| CLOPIXOL10 mg · Tablet | Zuclopenthixol | Canada | Marketed | 1997 |
| CLOPIXOL25 mg · Tablet | Zuclopenthixol | Canada | Marketed | 1997 |
| CLOPIXOL ACUPHASE50 mg / ml · Solution | Zuclopenthixol | Canada | Marketed | 1997 |
| CLOPIXOL DEPOT200 mg / ml · Solution | Zuclopenthixol | Canada | Marketed | 1997 |
| CLOPIXOL DEPOT 500MG/ML500 mg / ml · Liquid | Zuclopenthixol | Canada | Authorised | |
| FLUANXOL 0.5MG - TAB0.5 mg · Tablet | Flupentixol | Canada | Marketed | 1995 |
| FLUANXOL 3MG - TAB3 mg · Tablet | Flupentixol | Canada | Marketed | 1995 |
| FLUANXOL DEPOT 10%- LIQ IM 100MG/ML100 mg / ml · Solution | Flupentixol | Canada | Marketed | 1995 |
| FLUANXOL DEPOT 2% -LIQ IM 20MG/ML20 mg / ml · Solution | Flupentixol | Canada | Marketed | 1995 |
| TRINTELLIX20 mg · Tablet | Vortioxetine | Canada | Marketed | 2014 |
| TRINTELLIX15 mg · Tablet | Vortioxetine | Canada | Authorised | |
| TRINTELLIX5 mg · Tablet | Vortioxetine | Canada | Marketed | 2014 |
| TRINTELLIX10 mg · Tablet | Vortioxetine | Canada | Marketed | 2014 |
| VYEPTI300 mg / 3 ml · Solution | Eptinezumab | Canada | Marketed | 2024 |
| VYEPTI100 mg / ml · Solution | Eptinezumab | Canada | Marketed | 2022 |
| CIPRALEX MELTZ10 mg · Tablet (Orally-Disintegrating) | Escitalopram | Canada | Cancelled | 2012 |
| CIPRALEX MELTZ20 mg · Tablet (Orally-Disintegrating) | Escitalopram | Canada | Cancelled | 2012 |
| CLOPIXOL TABLETS 40MG40 mg · Tablet | Zuclopenthixol | Canada | Cancelled | 1997 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 26 | 22 | 4 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.